You finally took the plunge and started taking a GLP-1 drug to improve your health. You’re keeping up with your GLP-1 pill or ...

For the past three years, nearly every breakthrough in obesity medicine has traced back to a single class of drugs: GLP-1 ...

Through digital health company eMed, Brady, its chief wellness officer, and CEO Linda Yaccarino designed a fixed-cost program ...

This talk will describe the role of the clinical lab in advancing health equity. It will define the gaps in equitable access to lab testing and how that impacts patient care. We will also cover how ...

Retatrutide shows big weight loss potential but isn’t FDA-approved. Here’s what to know about its safety and legal risks.

“Peptide” is maybe the buzziest word in health care right now — but, as usual, the social media mania masks a much more ...

Explore how evolving obesity research is shaping trial design, with a focus on precision, reproducibility, and clinical ...

CEO Rob Fried reveals Niagen Bioscience’s NAD+ growth strategy, from Tru Niagen to their upcoming telehealth launch.

Peptides are all anyone wants to talk about right now, and the conversation is about to get louder with HHS Secretary Robert ...

New Wegovy Pill Prescriptions Written in First Two Months KELOWNA, BC / ACCESS Newswire / April 21, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX), (the "Company" or "Lexaria"), a global innovator ...

For Virginia Giuffre's family, it's been a hard year without her. Giuffre was one of the most prominent survivors of Jeffrey ...

Mounjaro is prescribed to treat obesity and has been in the headlines, as the scramble for GLP-1 drugs for weight-loss and ...